Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business
Private equity firm Advent International on Friday announced the completion of its majority acquisition of Hyderabad-based listed contract development and manufacturing organisation (CDMO) Suven Pharma. nnnRead more at: nhttps://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pe-advent-completes-acquisition-of-suven-pharma-appoints-new-board-and-management-team/articleshow/104050279.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Cabinet clears Advent's acquisition of Suven Pharma for Rs 9,589 crore
Reinventing Vitamin A for neonatal and pediatric unmet medical needsBronchopulmonary Dysplasia (BPD) is most frequent serious complication of preterm birth – US preterm births highest in 15...
DOYLESTOWN, Pa., July 18, 2023 (GLOBE NEWSWIRE) -- Advent Therapeutics, Inc., a biotechnology company pioneering an optimized retinol palmitate (vitamin A) drug product as a breakthrough...
Advent International Appoints Biopharma Executive James Mullen as Operating Partner
Advent, CVC Are Among Suitors for €3 Billion Viatris OTC Assets
Advent International (Advent), one of the largest and most experienced global private equity investors, has entered into a definitive agreement to acquire significant stake in Suven Pharmaceuticals (Suven Pharma) from the Jasti family, subject to regulatory approvals and conditions.
Private equity investors Blackstone and Advent International are in separate talks to buy a controlling stake in Suven Pharmaceuticals, Livemint reported on November 4, citing people with knowledge of the development.